Skip to main content
ASPHO Logo
Menu Journal My Account Contact Join/Renew
Login
  • Meetings & Events
    • Conference
      • 2022 Conference
        • 2022 Conference
        • Conference Registration
        • Accepted Papers and Posters
        • Full Schedule
        • Continuing Education
        • Back to Meetings
      • Meetings Archive
      • Press | 2018 Conference
      • 2018 Call for Papers and Posters
        • Back to Meetings
        • 2019 Conference
        • Schedule of Events
        • Registration Rates
        • Conference Planning Committee
        • Conference Hotel and Travel
        • Faculty
        • 2019 Call for Papers and Posters
        • Continuing Education
        • PBMTC
        • Accepted Papers and Posters
        • Corporate Symposia
        • MOC Opportunities
        • App - Thank you for Attending
        • 2019 Attendee List
      • 2019 Call for Workshops
      • 2018 Conference
        • Schedule of Events
        • Accepted Papers and Posters
      • 2016 Annual Meeting
        • Overview
        • Attendee List
        • ASPHO Virtual Bag
        • Corporate Forum Symposia/Education Theaters
        • Accepted Papers and Posters
          • Accepted A-G
          • Accepted H-M
          • Accepted N-Z
          • 2016 Searchable Abstract Database
        • Exhibit Hall
        • Sponsors
        • Annual Meeting Brochure
        • 2017 Call for Workshops
        • Virtual Bag
        • Schedule of Events
        • Continuing Education
        • Attendee List
        • 2017 Searchable Abstract Database
        • Accepted Papers and Posters
        • Corporate Forum Symposia/Education Theater
        • Travel
        • Program Committee
        • Commercial Support
        • Exhibit with ASPHO
    • Review Course
      • Anderson 2019
      • McClain 2019
      • Adams 2019
      • Moran 2019
      • Effinger 2019
      • 2021 Review Course
      • Schedule
      • Learning Objectives and CME
      • Faculty
      • Planning Committee
      • Review Course Archive
      • Fangusaro 2021
      • Brown 2021
      • Young 2021
      • Harker-Murray 2021
      • Effinger 2021
      • Pai 2021
      • Grace 2021
      • Rogers 2021
      • Anderson 2021
      • Powers 2021
      • McClain 2021
      • Neunert 2021
      • Fleming 2021
      • Mullen 2021
      • Pommert 2021
      • Meade 2021
      • Greengard 2021
      • Fox 2021
      • Bercovitz 2021
      • Brock 2021
      • Adams 2021
      • Loh 2021
      • O'Brien 2021
      • Walterhouse 2021
      • Pulsipher 2021
      • Oberley 2021
      • Rodriguez-Galindo 2021
      • Kesselheim 2021
      • Frei-Jones 2021
      • Allen 2021
      • 2015 Online Review Course CME Certificates
      • 2019 Planning Committee
      • 2019 Schedule
      • 2019 Travel
      • 2019 Review Course Early Career
      • 2019 Review Course Directors
        • 2019 Review Course Faculty
      • Oberley 2019
      • O'Brien 2019
      • Pai 2019
      • Pulsipher 2019
      • Rodriguez-Galindo 2019
      • Rogers 2019
      • Walterhouse 2019
      • Young 2019
      • Park 2019
      • Malec 2019
      • Evaluations
      • Brown 2019
      • Allen 2019
      • Fangusaro 2019
      • Fleming 2019
      • Frei-Jones 2019
      • Grace 2019
      • Harker-Murray 2019
      • Heeney 2019
      • Kesselheim 2019
      • Loh 2019
      • Mascarenhas 2019
      • Neunert 2019
    • Events Calendar
  • Knowledge Center
    • Products
      • Clinical Video Series
        • Clinical Video Series Disclosures
      • KARE Toolkit: Knowledge and Assessment Resources
        • CME for KARE
        • CME for RC On-Demand
        • CME for PHO Review Course On Demand
        • CME for KARE Plus
        • CME for KARE Plus Hematology
        • CME for KARE Plus Oncology
        • The KARE Toolkit - Index of Topics
      • Recordings
      • Webinars
      • ASPHOcast
      • 2020 Compensation Survey
    • Online Review Course
    • Pediatric Blood & Cancer
      • Access Journal
      • Online Access Instructions
    • ASPHO eNews
      • August 2015 Enews
      • June 2015 Enews
      • April 2015 Enews
      • February 2015 Enews
      • December 2014 Enews
      • October 2014 Enews
      • August 2014 Enews
      • June 2014 Enews
      • April 2014 Enews
      • February 2014 Enews
      • December 2013 Enews
      • October 2013 Enews
      • August 2013 Enews
      • June 2013 Enews
      • April 2013 Enews
      • February 2013 Enews
      • October 2014 Enews
      • October 2015 Enews
      • December 2015 Enews
      • February 2016 Enews
      • April 2016 Enews
      • June 2016 Enews
        • DSIG Student Registration
      • August 2016 Enews
      • October 2016 Enews
      • December 2016 Enews
      • February 2017 Enews
      • April 2017 Enews
      • June 2017 Enews
      • August 2017 Enews
      • October 2017 Enews
      • December 2017 Enews
      • February 2018 Enews
      • April 2018 Enews
      • June 2018 Enews
      • August 2018 eNews
      • October 2018 eNews
      • February 2019 eNews
      • Member Insights: eNews 2018 Highlights
      • April 2019 eNews
      • June 2019 eNews
      • August 2019 eNews
      • October 2019 eNews
      • December 2019 eNews
      • February 2020 eNews
      • April 2020 eNews
      • June 2020 eNews
      • August 2020 eNews
      • October 2020 eNews
      • December 2020 eNews
      • April 2021 eNews
      • June 2021 eNews
      • August 2021 eNews
        • August 2021 President's Message
      • December 2021 eNews
      • February 2022 eNews
      • April 2022 eNews
    • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
    • October 2015 Enews
    • Advocacy Sample
    • News Briefs
    • Health Policy & Advocacy
      • 2016 August Advocacy Brief
      • 2016 December Advocacy Brief
      • 2017 February Advocacy Brief
      • 2017 May Advocacy Brief
      • 2017 September Advocacy Brief
      • 2017 November Advocacy Brief
      • 2018 Advocacy Brief - March
      • Contact Your Members of Congress
      • 2018-Advocacy-Brief-June
      • 2018-Advocacy-Brief-September
      • Advocacy Brief December 2018
      • 2019 Advocacy Brief - March
      • March 2019 Advocacy Brief
      • June 2019 Advocacy Brief
      • September 2019 Advocacy Brief
      • March 2020 Advocacy Brief
      • June 2020 Advocacy Brief
      • September 2020 Advocacy Brief
      • December 2020 Advocacy Brief
      • June 2021 Advocacy Brief
      • September 2021 Advocacy Brief
      • December 2021 Advocacy Brief
      • March 2022 Advocacy Brief
    • 2017 Workforce Survey Report
    • Help Fund the STAT Act
    • Practice and Quality
      • Choosing Wisely®
      • Position Paper
      • Endorsements
      • ASPHO Endorsements member only
    • COVID–19 Resources
  • Career Development
    • Mentoring
      • Early Career Mentoring
    • Awards
      • Distinguished Career Award
      • Oski Memorial Lectureship
      • International Travel Awards
      • Arceci Innovation Award
      • Buchanan Lectureship
      • Young Investigator Award
      • Young Investigator Form
      • EC Travel Stipend Form
      • Early Career Travel Stipend
      • Advanced Practice Provider Award
      • Clinician Educator Award
      • Clinician Educator Award
      • Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
    • Career Center
    • Fellowship Resources
      • Post-PHO Fellowship Program Directory
      • Fellowship Program Directors' Resources
    • Certification
      • Continuing Medical Education
      • advocating for moc
      • ABP MOC Letter Nov 2015
      • ABP Hematology/Oncology Content Outline
    • 2019 ASPHO Award Recipients
    • Workforce
  • Membership
    • Who Belongs
    • Benefits
    • Join Us
    • Renew
    • Membership Application
    • Fellows Group Application
    • Member Community
    • Special Interest Groups
      • Adolescent and Young Adult SIG
      • Advanced Practice Provider SIG
      • Cancer Predisposition SIG
      • Clinical Immunology SIG
      • Diversity SIG
        • 2017 DSIG Travel Award
      • Global Hem Onc SIG
      • Hemoglobinopathy SIG
      • Hospitalist Medicine SIG
      • Informatics, Innovation and Entrepreneurship SIG
      • Integrative Pediatric Hematology/Oncology SIG
      • Palliative Care SIG
      • Physician Scientist SIG
      • Quality Improvement and Patient Safety SIG
      • Small Program SIG
      • Vascular Anomalies SIG
      • Clinical Immunology SIG Webinar
      • Well-Being SIG
    • Enriching the Future
      • ETF Donors
      • ETF FAQ
      • ETF Programs
      • ETF Award Recipients
      • Donate
    • Stay Connected with ASPHO
    • New Member
    • Trainee Membership Level
    • Strengthen Your Everyday Practice
  • About
    • Governance
      • 2017 Election Nominations
      • 2019 Board and Nominating Committee members
      • Board of Trustees
      • Leadership Development & Election Process
      • Nominating FAQs
      • Strategic Plan
        • Leadership Domain
        • Education Domain
        • Career Domain
        • Administration Domain
      • Volunteer Opportunities
        • Early Career Council
    • Policies
      • Advertising Sponsorship
      • Support of CME
      • Committee Policies, Responsibilities, and Resources
      • Conflict of Interest and Disclosure for Volunteers
      • Distinguished Career Award Eligibility Criteria
      • Diversity Statement
      • Investment
      • Member Mailing List
      • Oski Eligibility Criteria
      • Presidential Stipend
      • Records Retention
      • Reserve Fund
      • Reviews and Endorsements
      • Speaker Reimbursement
      • Surveying Members
      • Whistleblower
      • Workshop Session
      • Young Investigator Award
      • Early Career Travel Stipend
      • Buchanan Lectureship Eligibility
    • Terms of Use
    • Contact Us
    • 2016 Election Nominations
    • 2015 Election Candidates
    • FDA Approves Dinutuximab
    • Q&A Amy Billett
    • Fund Raising Policy
    • Support and Advertising
      • Exhibit
      • Advertising
      • Industry Relations Council
      • Grants
    • Diversity & Inclusion
    • Donate
  • 2017 Annual Meeting Session Recordings
  • 2018 Annual Meeting Session Recordings
  • George R. Buchanan Lectureship Award Presentation
  • Cancer Predispositions in Clinical Practice
  • Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
  • Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
  • Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
  • When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
  • Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
  • Award Presentations
  • Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
  • ZFNs, CrispR/Cas9 and TALENS- Oh My!
  • Collaboration in the Treatment of Liver Tumors
  • Leukemia
  • Solid Tumors/Lymphoma
  • Hematology I
  • Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
  • Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
  • It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
  • Children's Oncology Group (COG)
  • Outcomes Research
  • Social Media: The Good, The Bad, and Beyond
  • Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
  • Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
  • Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
  • Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
  • New Insights in Inherited Hematologic Diseases
  • Changing Workforce of Pediatric Hematology/Oncology
  • New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
  • New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
  • Physician, Sustain Thyself: Building Resilience to Prevent Burnout
  • Practicing Precision in Pediatric Oncology: Three Perspectives
  • What's Happening in DC? A Look at ASPHO Advocacy Efforts
  • Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
  • Brain Tumors
  • Hematology II
  • Sponsor, Exhibit, and Advertise
    • Exhibits
    • Advertising
    • Industry Relations Council
    • Exhibits Adveritising
  • Ward Testing OSE
  • 2018 Session | George R. Buchanan Lectureship Award Presentation
  • 2018 Session | Plenary Paper Session 2001-2002
  • 2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
  • 2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
  • 2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
  • 2018 Session | Iron: Let's Get Pumped
  • 2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
  • 2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
  • 2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
  • 2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
  • 2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
  • 2018 Session | Early Career Travel Stipend Awards
  • 2018 Session | Young Investigator Award Presentations
  • 2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
  • 2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
  • 2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
  • 2018 Session | Paper Session - Solid Tumor
  • 2018 Session | Paper Session - Hematology
  • 2018 Session | Vascular Anomalies: The Great Mimickers
  • 2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
  • 2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
  • 2018 Session | Paper Session - Children's Oncology Group (COG)
  • 2018 Session | Paper Session - Hematology Science
  • 2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
  • 2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
  • 2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
  • 2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
  • 2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
  • 2018 Session | Combating an Unmet Need: Psychosocial Health
  • 2018 Session | Renal Tumors Beyond Wilms
  • 2018 Session | Pediatric and Neonatal Transfusion Medicine
  • 2018 Session | Mobile Applications in Clinical Practice
  • 2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
  • 2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
  • 2018 Session | Emerging Therapies in Hemophilia
  • 2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
  • 2018 Session | Paper Session with Luminary Investigator - Leukemia
  • 2018 Session | Paper Session with Luminary Investigator - Hematology
  • 2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
  • December 2018 eNews
  • 2019 Session | Splenectomy - The Great Debate
  • 2019 Session | DICER1: Updates on Biology and Clinical Management
  • 2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
  • 2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
  • 2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
  • Models for International Pediatric Oncology Outreach
  • 2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
  • 2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
  • 2019 Session | The Microbiome: What Is It and Why Do We Care?
  • 2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
  • 2019 Session | Advances in Pediatric AML
  • 2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
  • 2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
  • 2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
  • 2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
  • 2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
  • 2019 Session | George R. Buchanan Lectureship Award Presentation
  • 2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
  • 2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
  • 2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
  • 2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
  • 2019 Session | Transforming the Treatment of Chronic Pain
  • 2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
  • 2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
  • 2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
  • 2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
  • 2019 Session | Oncofertility Programs: More Than Just Sperm Banking
  • 2019 Session | The (Financial) Cost of a "Cure"
  • 2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
  • 2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
  • 2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
  • 2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
  • 2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
  • 2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
  • 2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
  • 2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
  • 2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
  • 2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
  • 2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
  • 2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
  • 2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
  • 2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
  • 2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
  • 2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
  • 2019 Session | (2017) Levofloxacin Prophylaxis
  • 2019 Session | (2018) Renal Tumors: Future Roadmap
  • 2019 Session | (2019) Soft Tissue Sarcoma
  • 2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
  • 2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
  • 2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
  • 2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
  • 2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
  • 2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
  • 2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
  • 2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
  • 2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
  • 2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
  • 2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
  • 2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
  • 2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
  • 2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
  • 2019 Annual Meeting Session Recordings
  • CI SIG Webinar
  • October 2021 eNews

eNews

April 2022

Table of Contents

  • President's Message
  • Conference Central
  • Society News
    • Membership Approves Bylaws
    • Career Path Spotlight
    • Mid-Career Mentoring
  • Diversity Corner–April Is Celebrate Diversity Month
    • An Abundance of DEI Activities
    • DEI at #ASPHO2022
    • Expanding Inclusivity at ASPHO
  • Membership Bulletin
    • Workforce Publication Writing Group
    • National Volunteer Month
    • Committee Update
    • Special Interest Groups
  • Case Quiz
  • Industry Relations Council
  • Career Center

President's Message

Jorge Di Paola

Let's Reconnect and Refuel at #ASPHO2022

Jorge Di Paola, MD

Dear Friends and Colleagues, 

Finally! After 2 exhausting years of lockdowns, Zoom sessions, and virtual meetings, in May we will be able to gather in person for the 2022 ASPHO Conference in Pittsburgh. I am absolutely thrilled about it. This year’s meeting will offer amazing scientific and educational sessions, as well as the opportunity to network with colleagues and friends.

The Presidential Symposium will focus on the progress we have made over the last few decades in finding cures for what we used to call incurable diseases. We also have three Luminary Speaker presentations. Stephan A. Grupp, MD PhD, Chief of the Cellular Therapy and Transplant Section at Children’s Hospital of Philadelphia, will discuss revolutionary advances in cell therapy treatments for relapsed cancer. Julie Kanter, MD, Director of the Comprehensive Sickle Cell Disease Center at the University of Alabama at Birmingham, will report on new therapies for sickle cell disease, including gene therapy. And Steven W. Pipe, MD, Medical Director of the Pediatric Hemophilia and Coagulation Disorders Program at the University of Michigan and C.S. Mott Children’s Hospital, will update the Society on amazing new therapies for hemophilia.

I honestly believe this program will not only deliver on the substantial advances we have made over the past few decades but also energize fellows and junior faculty as they enter a completely different field governed by molecular medicine and new curative discoveries.

This final President’s Message from me to you also allows me to reflect on the past 2 years and my role as president. To say these past 2 years have been difficult for everyone would be a huge understatement. And yet, despite the COVID-19 pandemic, we have remained engaged as a Society, maintained most of our activities, and generated new ideas for the future through our strategic planning. I feel incredibly honored for the opportunity you gave me to serve ASPHO. We have an amazing Board of Trustees and committee chairs, as well as superb staff support that makes everything possible. I am pleased to see Dr. Doug K. Graham taking over the leadership. I have no doubts he will be a fantastic president. Thanks!

Jorge Di Paola, MD
President

Conference Central

Early Bird Registration Extended to April 12

#ASPHO2022–On-Site, Online, and On Demand

Register soon to reunite as a community at #ASPHO2022 and gain insights from 150 experts presenting state of the art education and science, 400 accepted posters and ASPHO Award recipients driving innovation and change in pediatric hematology/oncology. Early bird savings are extended through Tuesday, April 12, and special hotel room rates are available through Monday, April 18. In keeping with health and safety protocols there will be no onsite registration in Pittsburgh, so take advantage of the extended early bird registration! Registrants can change between in-person attendance in Pittsburgh and virtual access through April 12 for no charge.

Reinvigorate your knowledge and practice with the diverse education at #ASPHO2022, which offers on-site, online, and on-demand opportunities to provide a rewarding conference experience for every attendee in Pittsburgh and on the virtual conference platform, with  

  • live and on-demand education during the conference
  • on-site and online networking during the conference
  • on-demand education, CME, and networking through June 7.

Enhanced learning and networking opportunities are also available in Pittsburgh – watch a video to learn more. Additionally, now through May 7, every conference registrant can save 15% on the three Clinical Video Series bundles (savings applied at checkout). 

Register today!


Congratulations to the 2022 Young Investigator, Early Career, and Advanced Practice Professional Award Recipients!

The 2022 ASPHO Young Investigator Award Recipients will present their work on Wednesday, May 4. 

lisa maurer

Lisa Maurer, MD PhD, Children’s Hospital of Pittsburgh
Blocking the BCL10-MALT1 Interaction in Diffuse Large B-Cell Lymphoma

nathan dahl

Nathan Dahl, MD, Children’s Hospital Colorado
PTEFb-Dependent Transcription Reorganization Underpins the Glioma Adaptive Response To Radiotherapy

The 2022 Early Career Award Recipients will present their research during either a paper or poster session.

Eman Al-Antary, MD, Children’s Hospital of Michigan
Novel Therapy for Cytarabine-Resistant AML Utilizing the Combination of AZD5991 And ONC213

Sharmila Raghunandan, DO MPH, Children’s Healthcare of Atlanta/Emory University
Abatacept for the Prevention of GVHD in Pediatric Patients Receiving 7/8 HLA-Mismatched Transplant

Connor Hall, MD PhD, Johns Hopkins University School of Medicine
MTHFR Polymorphisms Are Associated with Decreased Methotrexate Tolerance in Pediatric ALL

Roma Rajput, MD, Children’s National Hospital
Standardized Thromboprophylaxis Protocol in Multisystem Inflammatory Syndrome in Children

Sherri Smart, MD PhD, Children’s Healthcare of Atlanta/Emory University
MERTK Inhibitior, MRX-2843, Is a Potential Novel Therapy in Pediatric Bone Sarcomas

The 2022 Advanced Practice Provider Award Recipient will present her research during a poster session.

Beth Speckhart, APN, University of Illinois College of Medicine Peoria
Increased Epigenetic Age in Childhood Cancer Survivors

Conference Health and Safety

To ensure the safety of all attendees, proof of COVID-19 vaccination will be required for registrants attending the 2022 ASPHO Conference in person in Pittsburgh, PA. Additional information on how to upload your vaccination documentation into the CLEAR app before you arrive in Pittsburgh is posted on the Health and Safety Webpage.


Society News

Membership Approves Bylaw Amendments

By an overwhelming majority, membership* approved bylaw amendments designed to strengthen governance practices and improve the member experience. The revised bylaws, which were unanimously recommended by the Board of Trustees to membership, go into effect at the conclusion of the 2022 ASPHO Conference.  

Key changes to the bylaws were suggested by various committees and special interest groups (SIGs), including the membership, training, and leadership development committees and the Diversity, Equity, and Inclusion SIG. The changes include:

  1. removing the barrier for an endorsement to join the organization
  2. being more inclusive by adding medical student and resident membership categories
  3. amending the quorum provision
  4. providing more clearly for video conferencing and other forms of virtual member meetings
  5. transforming the nominating committee into a leadership development committee to advance the Society, with an expanded year-round effort to invite, orient, train, and recognize volunteers
  6. incorporating other housekeeping-type revisions.

  As detailed on the Society’s recently launched governance webpages, the Leadership Development Committee has researched governance best practices over the past 2 years to more purposefully implement leadership development and build a strong and effective pipeline of volunteer leadership talent for ASPHO through a transparent process that encourages a diverse and inclusive environment. Changes in the bylaws to support these efforts include adopting 1-year terms for president, vice president, and immediate past president and creating a rigorous board elections process with a noncompetitive slate to better support diversity of the membership in every way—in specialty, professional setting, demographics, and other characteristics—in accordance with the Society’s Diversity Statement. 

ASPHO’s board thanks all those volunteers who contributed by recommending changes, developing new programs, and supporting our diversity efforts.  

*Per the bylaws, members eligible to vote include Regular and International members. 

Career Path Spotlight Series

The ASPHO Training Committee is pleased to present this month’s edition of the Career Path Spotlight series. This resource showcases the career paths of a variety of ASPHO physician members and informs medical students, residents, pediatric hematology/oncology (PHO) fellows, and early-career junior faculty members of the career opportunities available to them.

This month’s spotlight features Dr. Prerna Kumar from the University of Illinois College of Medicine Peoria in Peoria, IL.

prerna kumar

 

Access the April Spotlight

 

ASPHO’s Mid-Career Mentoring Program: Mentee Participants

The Professional Development Committee fielded a successful call for mentee applicants for our 2022–2023 Mid-Career Mentoring Program. To be eligible for consideration, applicants must have completed a primary PHO fellowship between 2006 and 2013. The committee received 17 applications with diverse mentorship needs. After careful vetting of the applications, and with consideration for multiple points of diversity, 10 applicants were selected to participate in this year’s program.

Congratulations to the following members for being selected to participate:

  • Jacquelyn Baskin-Miller, MD, UNC School of Medicine, Chapel Hill, NC 
  • Vivian Y. Chang, MD MS, UCLA Health, Los Angeles, CA 
  • Karen E. Effinger, MD MS, Children’s Healthcare of Atlanta, Atlanta, GA 
  • Jonathan Davi Fish, MD, Cohen Children’s Medical Center, New Hyde Park, NY 
  • Lisa Hartman, MD MAS, Children’s Hospital Colorado, Aurora, CO 
  • Monica L. Hulbert, MD, St. Louis Children’s Hospital, St. Louis, MO 
  • Jean Mulcahy Levy, MD, Children’s Hospital Colorado, Aurora, CO 
  • Karim Sadak, MD MPH MSE, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN 
  • Bhuvana A. Setty, MD, Nationwide Children’s Hospital, Columbus, OH 
  • Jodi L. Skiles, MD MS, Riley Hospital for Children at Indiana University Health, Indianapolis, IN 

Mentors for these members are currently being finalized. The 2022–2023 program will kick off in May with a group meeting at the 2022 ASPHO Conference in Pittsburgh. 

Diversity Corner

An Abundance of DEI Activities 

In recognition of April being Celebrate Diversity Month, the Diversity Advisory Group invited member reflections about diversity, equity, and inclusion (DEI) in the subspecialty. Read more for diversity-related thoughts from member colleagues, as well as 2022 ASPHO Conference sessions that address DEI issues in clinical trials and the workplace, and an update on expanded gender options for members, attendees, and customers. The Diversity Advisory Group invites members to continue the conversation throughout April on Twitter and include ASPHO’s handle, @ASPHO_hq, or in the Diversity, Equity, and Inclusion SIG community. Additional This email address is being protected from spambots. You need JavaScript enabled to view it. to the Diversity Advisory Group about DEI at ASPHO and in the subspecialty are always welcome.  

Member Reflections on DEI & PHO

kenneth chen

Kenneth S. Chen, MD
UT Southwestern Medical Center
Dallas, TX

As a physician scientist, my goal is to improve the care of children with cancer using data. With regards to DEI, the data suggest that we still have room to improve before the demographics of our field reflect the demographics of our patients. I serve on the Diversity Advisory Group to encourage ASPHO to continue gathering data on and addressing the barriers to diversity within the field of pediatric hematology and oncology.

Rosa Diaz MD 
I am a pediatric hematologist and oncologist from San Juan, Puerto Rico. I completed my pediatric residency at Cohen Children’s Medical Center in New Hyde Park, NY and then relocated to Houston, TX to pursue a fellowship in pediatric hematology and oncology and a clinical sub-fellowship in hemophilia and rare bleeding disorders at Texas Children’s Hospital. During my 10-plus years of clinical experience in Houston, I’ve encountered patients, families, trainees, and faculty from diverse backgrounds and have deeply enjoyed getting to know their stories. As a member of ASPHO’s Diversity Advisory Group, I aim to promote diversity, inclusion, and cultural competency to best meet the needs of not only the Society but also the patients and families we serve.  

john fargo

John Fargo, DO FAAP
Akron Children’s Hospital
Akron, OH

While it has taken me longer than I care to admit, I have learned and reflected internally a great deal about my explicit and implicit biases. As I continue in my career, it is even more evident how a diverse, inclusive team and organization are most successful at fulfilling the goals they set out to achieve. The Diversity Advisory Group is one area where I felt I could take what I have learned, and am still learning, and apply it to ASPHO’s mission of promoting optimal care of children, adolescents, and young adults with blood disorders and cancer.  

arun gurunathan

Arun Gurunathan, MD
Seattle Children's Hospital
Seattle, WA

My interest in being a member of ASPHO’s Diversity Advisory Group stems from a desire to see that ASPHO’s programming and leadership appropriately reflect the diversity of its membership as well as the patients ASPHO aims to serve, with resources that help underrepresented groups grow within ASPHO and providers give inclusive and culturally competent care. I am especially interested in decreasing the healthcare inequities faced by individuals and families with limited English proficiency.  
  

Kalindi Yajnik Narine, MD
Texas Children’s Hospital West Campus/Baylor College of Medicine
Houston, TX 

Diversity, equity, and inclusion are important in society as well as in ASPHO. They give different perspectives and encourages original thinking, helping us to understand our colleagues and our patients better. Pediatric hematology and oncology have diverse patient populations. DEI discussions and education will help us to understand and give better care to all our patients.  

carol o'hear

Carol O'Hear, MD PhD
Gilead Sciences
Foster City, CA

Given my job involves running global clinical trials, I am particularly interested in how the current lack of diversity in clinical trial enrollment can play a detrimental role in our ability to safely and effectively bring drugs to market. In pediatrics, the gap is less than in adult trials, but there are still gaps where enrollment in trials often does not match the distribution in gender, ethnicity, or other demographics in the overall population with that disease. In addition, as the leader for a large team, I have come to appreciate that diversity in my workforce has a direct impact on the success of our work. For example, when designing a trial that will be run in certain countries, insights from team members with different ethnicities have been valuable in making sure eligibility criteria and trial conduct are acceptable outside the United States. I am excited to continue as a member of the Diversity Advisory Group to advance opportunities for promoting diversity, inclusion, and cultural competency within the Society . 

maa ohui quarmyne

Maa-Ohui Quarmyne, MBChB MS, Phoenix Children's Hospital
Phoenix AZ

I am a pediatric hematologist at Phoenix Children’s Hospital and clinical associate professor at the University of Arizona College of Medicine in Phoenix. My life experiences and career path have taught me the importance of diversity and tolerance in our society. Diversity enriches our lives, spurs innovation, encourages engagement, improves tolerance, and reduces discrimination. I joined the Diversity Advisory Group in 2018, and through our group’s efforts and ASPHO as a larger organization, I hope to continue to engage our community in promoting effective strategies for a diverse, equitable workforce, which should hopefully lead to a better understanding of each other and greater satisfaction in our practice as a whole.   

nidhi shah

Nidhi Shah, DO
Attending Physician, Penn State Health
Hershey, PA

I am the current chair for the Diversity Advisory Group for ASPHO. I am interested in promoting ongoing DEI efforts at the institutional and national levels for our patients and their families as well as our colleagues.

william woods

William G Woods, MD
Professor and Director Emeritus, Aflac Cancer and Blood Disorders Centers
Emory University/Children’s Healthcare of Atlanta
Atlanta, GA
 
We are all saddened by Russia’s invasion of Ukraine. Through our sister society, the International Society of Paediatric Oncology (SIOP), there is a way to support work for kids with cancer in Ukraine, many of whom have moved to adjoining countries such as Poland.

What does this have to do with DEI? When an African, Asian, or South American country is invaded or taken over by an adjacent country or an internal civil war, why do news outlets in the United States spend not as much time reporting on them than they do for a Caucasian country such as Ukraine? Case in point: the genocide in Rwanda, with the Tutsi and Hutu indiscriminately killing everyone in sight in the opposite tribe. This is an example of white privilege, shining more light on what happens to Caucasian people than to people of color. Kids are killed in either situation, and we must promote the fact that we need to pay attention to the whole world’s kids.

DEI at #ASPHO2022

The 2022 conference includes sessions on common DEI issues that affect providers and patients, including clinical trials, communication to lead an anti-racist team, equity in academia, and ways to create a culture of respect. Learn about the sessions and presenters and save the calendar links to add the sessions to your schedule!

Pre-Conference Session: Clinical Trials in AYA Oncology: Diversity, Equity, Inclusion, and a Collaborative Approach, with moderators Kee Kiat Yeo, MD, and Stefanie M. Thomas, MD, and speakers Christabel Cheung, PhD MSW, and Nupur Mittal, MD. (Requires advance registration and additional fee.) 
Add to your calendar: Wednesday, May 4, 7:30-11:30am ET

Leading Anti-Racist Teams, a Hands-On Communications Workshop, with moderator Caitlin Neri, MD, and presenters Alexandra Power-Hays, MD, and Patrick McGann, MD MS 
Add to your calendar: Thursday, May 5, 3:45-4:45pm ET 

Moving the Needle: Equity in Academia, with moderators Jessica Heath, MD, Karen Effinger, MD, and speakers Sylk Sotto, EDD MBA MPS, and Nancy Spector, MD 
Add to your calendar: Friday, May 6, 3:45-5:15pm ET

Can You Hear Me Now?: Cultivating a Culture of Respect, Value, and Appreciation within Pediatric Hematology/Oncology, with moderator Scott Moerdler, MD, and Kathleen M. Sakamoto, MD PhD, Jeffrey S. Dome, MD PhD, and Cristina R. Fernandez, MD MPH 
Add to your calendar: Saturday, May 7, 8:45-9:45am ET

Expanding Inclusivity at ASPHO

In an effort to be inclusive, and in recognition of gender identity as potentially different from biological sex assigned at birth, the Diversity Advisory Group recommended expanding gender options for aspho.org transactions. Options now include 'Female, Male, Transgender, Gender non-conforming, Gender fluid, Other, and Prefer not to say' to encourage more personalized account profiles and ASPHO experience. The confidential information is stored in database records and used for anonymous data collection to understand and support membership.

Is your member profile up to date? Review your professional and personal information and support accurate data collection and specialist representation.


Membership Bulletin

Workforce Publication Writing Group

ASPHO is dedicated to understanding current and future workforce dynamics within the subspecialty. As part of our workforce strategy, we have continued our workforce data collection efforts, most recently with the completion of our Workforce and Productivity Survey in late 2021. The Society is eager to share findings of these survey efforts and help paint a picture of the PHO workforce.

A diverse workforce publication writing group has been appointed to develop a valuable manuscript based upon findings from our workforce-based surveys completed between 2018 and 2021. This publication will highlight and inform the PHO workforce and will include information on the scope of practice and current workforce composition. The writing group comprises physician members from different practice settings and program sizes as well as various primary subspecialties within PHO. The group includes the following core members:

  • Caroline Hastings, MD, UCSF Benioff Children’s Hospital Oakland, Oakland, CA 
  • Michelle P. Hudspeth, MD, Medical University of South Carolina, Charleston, SC
  • John Bergsagel, MD, Children’s Healthcare of Atlanta, Atlanta, GA 
  • Scott C. Borinstein, MD PhD, Vanderbilt Children’s Hospital, Nashville, TN 
  • J. Nathan Hagstrom, MD MHCM, Lehigh Valley Reilly Children’s Hospital, Allentown, PA, 
  • Patrick Leavey, MD, University of Texas Southwestern Medical Center, Dallas, TX
  • Diane J. Nugent, MD, Children’s Hospital of Orange County, Orange, CA

Drs. Hastings and Hudspeth are serving as co–lead writers for the group, which will be meeting soon to begin the manuscript development process. The group’s goal is to have a final draft developed by late summer. Following board approval, the manuscript will be submitted for publication in Pediatric Blood & Cancer.   

Thank You to Our Volunteers!

ASPHO thanks our 2021–2022 member volunteers! As we begin National Volunteer Month, ASPHO would like to honor and highlight the contributions of our member volunteers. Their contributions and dedication enable us to fulfill our strategic goals and further our mission.

A big thank you to each of our 2021–2022 member volunteers. Whether you served on a standing committee or task force, volunteered as a liaison to an external partner, contributed through member publications, or were involved in an ad hoc project, we appreciate your commitment to ASPHO!

ASPHO is also excited to welcome incoming committee volunteers as they begin their terms on standing committees. We hope that you find personal fulfillment from being an integral part of your profession and ASPHO’s progress!

ASPHO provides a year-round open application process to be considered for committee openings. Those submitting applications now through this winter will be considered for committee vacancies for the 2023–2024 Society year. For further information on ASPHO committees and to access the application, please visit our committee webpage.

Committee Update

The Conference Planning Committee’s primary focus is to develop the ASPHO Conference content and related activities, including selecting symposia programming and faculty and reviewing and selecting workshops and abstracts for presentation. The committee’s work begins a full calendar year ahead of the conference, as committee members review the gap analysis, needs assessment, and previous years' conference evaluations to begin to outline topics for conference programming. Committee members are tasked with proposing session topics that address the identified needs.

During the summer, a full request for proposals is conducted, allowing the PHO community to propose topics and sessions during the call for workshops. By the end of the summer, the committee has reviewed all of the proposals and work continues to develop the overall selection of conference sessions.

In the fall, the call for abstracts opens, allowing the PHO community to submit abstracts outlining current research activity. The committee reviews each abstract (typically more than 450) to determine acceptance decisions for poster presentations and oral paper presentations. During this acceptance process, the committee also reviews award applications and identifies the recipients for the Young Investigator (YI) Award, Early Career Travel Stipend Award, and Advanced Practice Provider Travel Stipend Award, to be presented during the conference.

Under the leadership of Chair Valerie Brown, MD PhD, and Vice-Chair Karen Effinger, MD MS, and supported by Board Liaison Sarah Alexander, MD, the committee is commended for its exemplary work in building and delivering a highly rated educational program for annual ASPHO Conferences. After canceling the 2020 conference and offering a fully virtual conference in 2021 due to the COVID-19 pandemic, the committee is excited to welcome the PHO community back to an in-person event at the 2022 conference in Pittsburgh.


Special Interest Groups for Every Member

Spring is the perfect time to join the member communities that support your interests. SIG members can vote in upcoming Vice-Chair elections and be part of year-round conversations and resource sharing. Learn about ASPHO’s 16 SIGs, including the new Hospitalist Medicine community, on aspho.org and at the SIG Meet & Greet during the 2022 ASPHO Conference.


Case Quiz

case quizA 6-month-old with Failure to Thrive

A 6-month-old female was admitted for evaluation of failure to thrive. Born via an uncomplicated term vaginal delivery, she was noted to be small for gestational age without additional complications. Within the first month of life, she started having frequent post-feed emesis and quickly dropped off the growth chart. She was initially worked up for failure to thrive at 5 months of age. A routine lab evaluation noted a transaminitis, and upper gastrointestinal series and abdominal ultrasound were unremarkable. Her lab findings were attributed to malnutrition, and she was started on EleCare feeds every 3 hours. She demonstrated some initial weight gain; however, this was not sustained, and she was readmitted for further evaluation and nasogastric tube placement for continuous overnight feeds.

The child has no prior medical history of recurrent fevers or infections and had a normal newborn screen at birth. She has been meeting all developmental milestones.

Laboratory Evaluation: 

  • WBC: 6.37 x 109/L 
  • Hemoglobin: 10.9 g/dL 
  • Platelets: 300 x 109/L 
  • Absolute neutrophil count: 0.64 x 103/mcL
  • Total bilirubin: 0.2 mg/dL 
  • ALT: 606 unit/L 
  • GGT: 60 unit/L 
  • AST: 186 unit/L 
  • LDH: 775 unit/L 

The genetics team was consulted to aid in evaluation of possible causes of failure to thrive, transaminitis, and neutropenia. With this clinical scenario, which gene would you be MOST interested in testing for? 

Take the quiz. 

Sarah McDermott, DO MBS and Lauren E. Amos, MD
Division of Pediatric Hematology/Oncology
Children’s Mercy Hospital, Kansas City, MO

IRC

Thank You to our Industry Relations Council Members!

Premier Level

bluebird bio

NEW BluebirdBio

Executive Level

JazzPharmaceuticals


Career Center

Find Job Opportunities in PHO

Take advantage of Career Center resources for your job search!

ASPHO's Career Center offers resources for resume writing, coaching, reference checks, and more to stay on top of job openings and hiring trends in the field. Skim the Resources section for resume writing, coaching, reference check, search strategy videos, and more. Create a personal account to save job postings and skim FAQs to learn how to best navigate the site! The Career Center is the go-to source where institutions post employment and targeted recruitment opportunities in the field.

Be an #ASPHOAdvocate!

Are you up-to-date on ASPHO's advocacy efforts? Visit aspho.org/advocacy for the latest issue of Advocacy Brief and to learn about important legislative and regulatory issues and #ASPHOadvocacy efforts to support members, patients, and the profession.

  • Products
    • Clinical Video Series
    • KARE Toolkit: Knowledge and Assessment Resources
    • Recordings
    • Webinars
    • ASPHOcast
    • 2020 Compensation Survey
  • Online Review Course
  • Pediatric Blood & Cancer
    • Access Journal
    • Online Access Instructions
  • ASPHO eNews
    • August 2015 Enews
    • June 2015 Enews
    • April 2015 Enews
    • February 2015 Enews
    • December 2014 Enews
    • October 2014 Enews
    • August 2014 Enews
    • June 2014 Enews
    • April 2014 Enews
    • February 2014 Enews
    • December 2013 Enews
    • October 2013 Enews
    • August 2013 Enews
    • June 2013 Enews
    • April 2013 Enews
    • February 2013 Enews
    • October 2014 Enews
    • October 2015 Enews
    • December 2015 Enews
    • February 2016 Enews
    • April 2016 Enews
    • June 2016 Enews
    • August 2016 Enews
    • October 2016 Enews
    • December 2016 Enews
    • February 2017 Enews
    • April 2017 Enews
    • June 2017 Enews
    • August 2017 Enews
    • October 2017 Enews
    • December 2017 Enews
    • February 2018 Enews
    • April 2018 Enews
    • June 2018 Enews
    • August 2018 eNews
    • October 2018 eNews
    • February 2019 eNews
    • Member Insights: eNews 2018 Highlights
    • April 2019 eNews
    • June 2019 eNews
    • August 2019 eNews
    • October 2019 eNews
    • December 2019 eNews
    • February 2020 eNews
    • April 2020 eNews
    • June 2020 eNews
    • August 2020 eNews
    • October 2020 eNews
    • December 2020 eNews
    • April 2021 eNews
    • June 2021 eNews
    • August 2021 eNews
    • December 2021 eNews
    • February 2022 eNews
    • April 2022 eNews
  • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
  • October 2015 Enews
  • Advocacy Sample
  • News Briefs
  • Health Policy & Advocacy
    • 2016 August Advocacy Brief
    • 2016 December Advocacy Brief
    • 2017 February Advocacy Brief
    • 2017 May Advocacy Brief
    • 2017 September Advocacy Brief
    • 2017 November Advocacy Brief
    • 2018 Advocacy Brief - March
    • Contact Your Members of Congress
    • 2018-Advocacy-Brief-June
    • 2018-Advocacy-Brief-September
    • Advocacy Brief December 2018
    • 2019 Advocacy Brief - March
    • March 2019 Advocacy Brief
    • June 2019 Advocacy Brief
    • September 2019 Advocacy Brief
    • March 2020 Advocacy Brief
    • June 2020 Advocacy Brief
    • September 2020 Advocacy Brief
    • December 2020 Advocacy Brief
    • June 2021 Advocacy Brief
    • September 2021 Advocacy Brief
    • December 2021 Advocacy Brief
    • March 2022 Advocacy Brief
  • 2017 Workforce Survey Report
  • Help Fund the STAT Act
  • Practice and Quality
    • Choosing Wisely®
    • Position Paper
    • Endorsements
    • ASPHO Endorsements member only
  • COVID–19 Resources
Daichi injectafer
Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us
Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology